roderick.png

Educational Info

Honours Bachelor of Science, Human Biology (1995), University of Toronto
Doctor of Microbial Genetics (2002), University of Saskatchewan
Master of Business Administration, Biotechnology Management and Commercialization (2006), Edwards School of Business, University of Saskatchewan

Roderick Slavcev, PhD, MBA, MRSB C. Biol

About Roderick

Roderick Slavcev specializes in microbial genetics and biochemistry of nucleic acids with experience in both academic and industrial settings. Prior to gathering valuable marketing and clinical experience as a medical liaison for the pharmaceutical industry he completed his post-doctoral fellowship at the Department of Medical Genetics and Microbiology at the University of Toronto in the area of bacteriophage P1 plasmid partition and chromosomal segregation. His current research group comprises Mediphage Bioceuticals (MB) encompasses genetics, molecular biology, virology and technology transfer with the ultimate aim of bringing new treatments to the global environment, especially less developed countries. MB research projects focus on the exploitation of bacteriophage-based biotechnology and include the use of coliphages and phage-encoded genes and genetic elements to design and construct vectors for the development of novel vaccines, biopharmaceuticals and gene therapy systems, and the identification and application of novel phage genomic anti-bacterial genes to treat and dispose of the clinical culprits of global bacterial infection.

Roderick comes to the University of Waterloo with a MBA specialized in biotechnology management and commercialization. As the Professor of Business and Entrepreneurship, Roderick currently directs and delivers the School of Pharmacy's award-winning business curriculum initiative. He was also instrumental in the designing and development of the first Medical Microbiology Laboratory to be offered by a Canadian Pharmacy curriculum and leads the development of a Continuing Education initiative to bring Strategic Management and Leadership to practicing pharmacists.

 

Published Books . . .

  • Jessica Nicastro, Shirley Wong, Zahra Khazaei, Peggy Lam, Jonathan Blay, Roderick A. Slavcev. Bacteriophage Applications—Historical Perspective and Future Potential. Cham: Springer Nature Publishing, 2017.
  • Slavcev, Roderick A., Alan Low, Jason Perepelkin, Rita Winn, Kevin Hall, Mike Jaczko, Dayle Acorn, , eds. Pharmacy Management in Canada. Vol. 1. Toronto: Brush Publishing, 2015.
  • Slavcev, Roderick A. Tackling the classical genetic mystery of the bacteriophage λ Rex phenotype. Köln: Lambert Academic Publishing, 2010.

Published Book Chapters . . .

  • Enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut Nicastro, J. An overview of bacteriophage lifecycles and applications. In: Bacteriophage Applications—Historical Perspectives and Future Applications, Springer/Nature Publishing (In Press).
  • Nicastro, J., Wong, S., and R.A. Slavcev. Bacteriophages functionalized for gene delivery and the targeting of gene networks. In: Bacteriophage Applications—Historical Perspectives and Future Applications, Springer/Nature Publishing (In Press).
  • Wong, S. Phage probiotics. In: Bacteriophage Applications—Historical Perspectives and Future Applications, Springer/Nature Publishing (In Press).
  • Khazaei, Z., Nicastro, J. and R.A. Slavcev. Phage for biodetection. In: Bacteriophage Applications—Historical Perspectives and Future Applications, Springer/Nature Publishing (In Press).
  • Nicastro, J., Wong, S., and R.A. Slavcev. Phage-mediated immunomodulation. In: Bacteriophage Applications—Historical Perspectives and Future Applications, Springer/Nature Publishing (In Press).
  • Nicastro, J. and R.A. Slavcev. Phage for biodetection. In: Bacteriophage Applications—Historical Perspectives and Future Applications, Springer/Nature Publishing (In Press).
  • Lam, P., Nicastro, J. and J. Blay Phage device coatings. In: Bacteriophage Applications—Historical Perspectives and Future Applications, Springer/Nature Publishing (In Press).
  • Slavcev, R.A. 2015. The Pharmacy Industry Landscape—Where are we? Where do we need to go and how do we get there? In: Pharmacy Management in Canada, Canadian Foundation for Pharmacy, Brush Publishing.
  • Slavcev, R.A. 2015. Microenvironmental, industry analysis. In: Pharmacy Management in Canada, Canadian Foundation for Pharmacy, Brush Publishing.
  • Slavcev, R.A. 2015. Assessing the critical attributes of a new venture. In: Pharmacy Management in Canada, Canadian Foundation for Pharmacy, Brush Publishing.
  • Kaur, T., and R.A. Slavcev*. 2013. Solid Lipid Nanoparticles: “Tuneable Anti-Cancer Gene/Drug Delivery Systems”. In: Gene Therapy/Book 1, InTech Open Access Publisher. DOI: 10.5772/54781
  • Kaur, T., S. Wettig, and R.A. Slavcev* 2011. Nanomedicine-based approaches to cancer diagnosis and therapy. In: Gene Therapy, InTech Open Access Publisher.
  • Wettig, S., Kaur, T., Tavakoli, N., and R.A. Slavcev*. 2011. Calorimetric investigations of non-viral DNA transfection systems. In: Thermodynamics, InTech Open Access Publisher.
  • Two additional chapter contributions in ASM Book on plasmid partition and Lambda Rex Phenotype

Educational Articles . . .

  • Slavcev, R. 2016. New Pharmacy and NuRx: Doing good while doing well. Pharmacy Business (In Press)
  • Slavcev, R.A., Waite, N., and Jennings, B. 2016. Shaping pharmacy studentsʼ business and management aptitude and attitude. Currents in Pharmacy Teaching and Learning, 8: 672 - 680.
  • Slavcev, R.A. 2016. NuRx – Exploring a new model of pharmacy in Canada. Pharmacy Business, July/Aug 2016.
  • Slavcev, R.A. 2014. Part III. Paradigm shifts in healthcare. Canadian Healthcare Network, September 16. [http://www.canadianhealthcarenetwork.ca/pharmacists/discussions/blogs/new-pharmacy/part-3-paradigm-shifts-in-health-care-27539]
  • Slavcev, R.A. 2014. Part II. Paradigm shifts in healthcare. Canadian Healthcare Network, August 11. [http://www.canadianhealthcarenetwork.ca/pharmacists/discussions/blogs/new-pharmacy/part-2-paradigm-shifts-in-health-care-27173].
  • Slavcev, R.A. 2014. Part I. Paradigm shifts in healthcare. Canadian Healthcare Network, August 11.[http://www.canadianhealthcarenetwork.ca/pharmacists/discussions/blogs/new-pharmacy/part-2-paradigm-shifts-in-health-care-27173]
  • Slavcev, R.A. 2014. Value-driven pharmacy: Doing good while doing well. Canadian Healthcare Network, July 10. [http://www.canadianhealthcarenetwork.ca/pharmacists/discussions/blogs/new-pharmacy/value-driven-pharmacy-doing-good-while-doing-well-26837]
  • Huang, E. and R.A. Slavcev*. 2013. A Celebration of the Innovation and Entrepreneurship at University of Waterloo 2nd Annual Business Awards Ceremony. Canadian Pharmacists Journal/Revue des Pharmaciens du Canada 146: 251-252.
  • Slavcev, R.A.* Cheung, D., and J. Tjendra. 2013. A needs-driven model for strategic pharmacy education. Currents in Pharmacy Teaching and Learning 5: 593-599.
  • Slavcev, R.A.*, Tjendra, J., Boran, V. and N. Kanji. 2013. Pharmacy Investment Club: Fostering financial management skills from beyond the classroom. Canadian Pharmacists Journal/Revue des Pharmaciens du Canada 146: 144-145.
  • Slavcev, R.A.*, and A. Patel. 2012. Industrial Case Competition: Where Healthcare Interfaces Innovation. CPJ/RPC 145: 251.
  • Tjendra, J., Slavcev, R.A.*, and M. Stanley. 2012. University of Waterloo celebrates innovation and entrepreneurship. Canadian Pharmacists Journal/Revue des Pharmaciens du Canada 145:6-7.
  • Wasfi, O., Power, M., and R.A. Slavcev.* 2011. An outcomes-based model for medical microbiology curricular assessment and design in pharmacy at the University of Waterloo. Opportunities and New Directions 2: 91-99.
  • Wasfi, O., Power, M., and R.A. Slavcev.* 2010. Clinical Microbiology in Pharmacy Education: A Practice-based Approach. Journal of Medical and Biological Education 11: 135-139.
  • Cheung, D., Nguyen, L., Shamsoun, G. and R. Slavcev. 2010. Education meets enterprise: The implementation of the UW School of Pharmacy clinical capstone. UW Press, 26 pp.
  • Slavcev, R.A. 2008. School of Pharmacy Strategic Management Plan and Business Curriculum.
  • Slavcev, R.A. 2006. MediPhage Bioceuticals, Inc.: Feasibility Study. University of Saskatchewan Press.

Patents . . .

  • Slavcev, R. and N. Nafissi. 2016. DNA Vector System. US9290778
  • Slavcev, R. and J. Nicastro. 2014. A Fine-tuned Lytic Phage Display System. USPTO serial #: 61/815467 (Filed April 14th, 2014)
  • Slavcev, R. and N. Nafissi. 2014. In vivo linear covalently closed DNA vector production system. USPTO serial # US 20140206037 A1 (Filed Nov. 22, 2013)
  • Slavcev, R., Kaur, T., Nafissi, N. and S. Wettig. 2010. Safe and Efficient Gene Therapeutics: A Novel Polyplexed Mini-Linear Covalently Closed Transgene Delivery System with Application to Cancer Gene Therapy. USPTO serial #: 61/344,851. (Provisional Abandoned)

Presentations and Abstracts . . .

  • Alattas, H., Slavcev, R.A. 2016. Isolation and Characterization of Host Mutations that Suppress the Bacteriophage Lambda Rex Phenotype. Molecular Genetics of Bacteria and Phages Meeting; University of Wisconsin, Madison, USA.
  • Wong, S., R.A. Slavcev. 2015. DNA Ministrings: Linear covalently closed DNA minivectors for use in non-viral gene therapy with applications toward ovarian cancer. American Society of Gene and Cell Therapy 18th Annual Meeting. New Orleans, USA.
  • Nicastro, J., R.A. Slavcev. 2014. Construction and characterization of an HIV DNA-VLP vaccine using bacteriophage Lambda. Waterloo Institute for Nanotechnology (WIN). Graduate Student Research Seminar Series. Waterloo, Canada.
  • Wong, S., Nafissi, N. Sum, Chi Hong, and R. Slavcev.* 2014. Delivery of toxic topoisomerase mutant alleles by DNA ministrings for ovarian cancer gene therapy. Institute for Comparative Cancer Investigation (ICCI). May 15, Guelph, Canada.
  • Sum, C.H., Nafissi, N., Slavcev, R. 2014. Optimized production of a Safe and Efficient Gene Therapeutic Vaccine versus HIV via a Linear Covalently Closed DNA Minivector. International Symposium HIV and Emerging Infectious Diseases (ISHEID) Conference, May 21-24, Marseille, France Nicastro, J., Slavcev, R.A. 2013. Construction and analysis of a genetically tuneable lytic phage display system. International Evergreen Phage Conference, August 4, Olympia, USA
  • Sum, C. H., Nafissi, N., Slavcev, R.A. 2013. Downstream development of HIV DNA-VLP vaccine upon optimization of linear covalently closed (LCC) mini-plasmid production. 4th Annual Canadian Pharmacy Education & Research Conference, June 11, Niagara-on-the-Lake, Canada [Winner of Whit-Matthews Graduate Student Poster Award]
  • Nicastro, J., Slavcev, R.A. 2013. Construction and characterization of a genetically tuneable dsDNA Phage Display System using bacteriophage lambda. 4th Annual Pharmacy Education and Research Conference, June 11, Niagara-on-the-lake, Canada
  • Nafiseh, N., Slavcev, R.A. 2013. Ministring DNA vectors: The gold standard for gene delivery in molecular medicine. American Association of Gene and Cell Therapy (ASGCT). May 15, Salt Lake City, USA.
  • Nafiseh, N., Slavcev, R.A. 2013. Development of a highly safe and efficient pDNA vector production system for non-viral gene delivery. The 4th Annual World DNA and Genome Day 2013; Congress of International Bio-Pharmaceutical Cooperation and Innovation 2013. April 27, Nanjing, China.
  • Sum, C. H., Slavcev, R.A., Wettig, S. D. 2012. Comparative analysis of DNA topology on gene delivery mediated by gemini surfactant/DOPE nanoparticles. 3rd Annual Nano Ontario Conference, October 11, Waterloo, Canada.
  • Sum, C. H., Nafissi, N., Slavcev, R.A., Wettig, S. D. 2012. Enhanced gene delivery through gemini surfactant mediated transfection of linear covalently closed (LCC) mini-plasmids. 19th International Symposium on Surfactants in Solution 2012 (SIS2012), June 24, Edmonton, Canada [Winner of Best poster award]

Invited Talks . . .

  • Slavcev, R.A. 2016. DNA Ministrings: Building Safety and Efficacy into Gene Therapy. CIHR Drug Safety and Efficacy Cross-disciplinary Training Symposium. April 27, Toronto, Ontario.
  • Slavcev, R.A. 2016. Pharmacy management in Canada: A new course. Canadian Pharmacist Association. June 25, Calgary, Canada [deferred]
  • Slavcev, R.A. 2015. Biotechnology Commercialization. Biotechnology Entrepreneurship Conference. October 7, Windsor, Canada [Panelist]
  • Slavcev, R.A. 2015. Value-driven Pharmacy. Pharmacy U Toronto. February 7, Toronto, Ontario [Keynote speaker]
  • Slavcev, R.A. 2014. New Pharmacy: Healthcare’s Disruptive Technology. Pharmacy U Vancouver. November 22, Vancouver, Canada [Keynote speaker]
  • Slavcev, R.A. 2014. Value-driven Pharmacy: Doing Good While Doing Well. Canadian Foundation for Pharmacists Forum. October 15, Mississauga, Canada [Keynote speaker].
  • Slavcev, R.A. 2014. Building Safety and Efficiency into Health Technology Development. Ontario University Biosafety Association Meeting. August 21, Waterloo, Canada.
  • Slavcev, R.A. 2014. Effective Leadership: the Strategic Management of Meaning. CIHR Drug Safety and Effectiveness Cross-Disciplinary Training Symposium. March 21, Ottawa, Canada.
  • Slavcev, R.A. 2014. The Extraction of Value from Knowledge: The Hybridization of Science and Business in Healthcare. Pharmacy Research Seminar Series. February 12, Toronto, Canada.
  • Slavcev, R.A. 2013. Strategic Pharmacy. Introduction to models and methods of research in clinical, social, and administrative pharmacy. November 8, Toronto, Canada [Expert panelist].
  • Slavcev, R.A. 2013. Fundamental Principles of Leadership: A corporate perspective. DSECT Symposium, June 21, Hamilton, Canada.
  • Slavcev, R.A., and E. Brown. 2013. Venturing into other scientific domains and back again from drug discovery research: A focus on antibiotics. DSECT Symposium, June 20, Hamilton, Canada.
  • Slavcev, R.A. 2013. Bridging domains in academia: Creating value through chaos. 7th Annual Life Science Career Development Day. May 31, Waterloo, Canada [Keynote Speaker].
  • Slavcev, R.A. 2013. DNA nanostrings and nanospheres: A paradigm shift in gene therapy nanomedicine. April 27, 4th World DNA and Genome Day, Nanjing, China [Session Co-chair]
  • Slavcev, R.A. 2013. Strategically Translating Education. Fusion Conference 2013: Ignite your passion. March 7, Waterloo, Canada [Keynote Speaker]
  • Slavcev, R.A. 2012. Leadership and Managing Meaning. CPhA Conference, June 3, Whistler, Canada.
  • Slavcev, R.A. 2012. Pharmaceutical Applications of a novel Linear Safe DNA (LSD) system. 2nd World Congress on Bioavailability and Bioequivalence: Pharmaceutical R&D Summit. December 16, 2012. San Francisco, USA [Keynote Speaker and Session Chair]
  • Slavcev, R.A. 2012. Development of a Highly Safe and Efficient pDNA Vector Production System for Non-Viral Gene Delivery. 3rd World DNA and Genome Day. April 27, Xi’an, China [Session Chair]
  • Slavcev, R. 2012. Science in the New Age. Redefining the Norm. Fusion Conference 2012: Redefining the Norm, March 9, Waterloo, Canada [Keynote Speaker]
  • Slavcev, R.A. 2011. Pharmacy management in the new world. Ontario Pharmacists Association Business 2.0, October 23, Toronto, Canada [Keynote speaker]
  • Slavcev, R.A. 2011. Genetic approach to the construction of a controllable phage display platform for use in optimized therapeutic development. Pharmaceutics & Novel Drug Delivery Systems, June 8, Las Vegas, USA [Session Chair]